Literature DB >> 18024204

Chronic widespread musculoskeletal pain - a comparison of those who meet criteria for fibromyalgia and those who do not.

Lars Cöster1, Sally Kendall, Björn Gerdle, Chris Henriksson, Karl G Henriksson, Ann Bengtsson.   

Abstract

Fibromyalgia is currently classified as chronic widespread pain with widespread allodynia to pressure pain. There are few data describing pain characteristics, quality of life, consequences for daily living, and psychosocial status in patients who meet the classification criteria for fibromyalgia proposed by the American College of Rheumatology compared with patients with chronic widespread pain but not widespread allodynia. This study used a randomly selected sample from the general population. A postal questionnaire and a pain mannequin were sent to 9952 people. The response rate was 76.7%. The pain drawings showed that 345 people had widespread pain; that is, they noted pain in all four extremities and axially. Clinical examination, which included a manual tender point examination, was performed in 125 subjects. These people answered commonly used questionnaires on pain, quality of life, coping strategies, depression, and anxiety. Compared with chronic widespread pain without widespread allodynia, fibromyalgia was associated with more severe symptoms/consequences for daily life and higher pain severity. Similar coping strategies were found. Chronic widespread pain without widespread allodynia to pressure pain was found in 4.5% in the population and fibromyalgia in 2.5%.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18024204     DOI: 10.1016/j.ejpain.2007.10.001

Source DB:  PubMed          Journal:  Eur J Pain        ISSN: 1090-3801            Impact factor:   3.931


  33 in total

1.  [AWMF guidelines for fibromyalgia syndrome].

Authors:  W Hardinghaus
Journal:  Schmerz       Date:  2008-12       Impact factor: 1.107

2.  Fibromyalgia and the Prediction of Two-Year Changes in Functional Status in Rheumatoid Arthritis Patients.

Authors:  Hyein Kim; Jing Cui; Michelle Frits; Christine Iannaccone; Jonathan Coblyn; Nancy A Shadick; Michael E Weinblatt; Yvonne C Lee
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-11-14       Impact factor: 4.794

3.  Illness perception and fibromyalgia impact on female patients from Spain and the Netherlands: do cultural differences exist?

Authors:  Pedro J Ruiz-Montero; C Paul Van Wilgen; Victor Segura-Jiménez; Ana Carbonell-Baeza; Manuel Delgado-Fernández
Journal:  Rheumatol Int       Date:  2015-05-13       Impact factor: 2.631

Review 4.  [Fibromyalgia].

Authors:  M Späth
Journal:  Z Rheumatol       Date:  2011-09       Impact factor: 1.372

5.  Fatigue in fibromyalgia: a conceptual model informed by patient interviews.

Authors:  Louise Humphrey; Rob Arbuckle; Philip Mease; David A Williams; Bente Danneskiold Samsoe; Claire Gilbert
Journal:  BMC Musculoskelet Disord       Date:  2010-09-20       Impact factor: 2.362

6.  [Prevalence of chronic pain in Germany. A representative survey of the general population].

Authors:  W Häuser; G Schmutzer; A Hinz; A Hilbert; E Brähler
Journal:  Schmerz       Date:  2013-02       Impact factor: 1.107

Review 7.  Chronic widespread pain and fibromyalgia: two sides of the same coin?

Authors:  Roland Staud
Journal:  Curr Rheumatol Rep       Date:  2009-12       Impact factor: 4.592

8.  Fibromyalgia syndrome module at OMERACT 9: domain construct.

Authors:  Philip Mease; Lesley M Arnold; Ernest H Choy; Daniel J Clauw; Leslie J Crofford; Jennifer M Glass; Susan A Martin; Jessica Morea; Lee Simon; C Vibeke Strand; David A Williams
Journal:  J Rheumatol       Date:  2009-10       Impact factor: 4.666

9.  [Intensity of limb pain and fatigue in fibromyalgia syndrome, depressive disorders and chronic back pain. A criterion for differentiation].

Authors:  W Häuser; N Grulke; D Michalski; A Hoffmann; I Akritidou; S Klauenberg; C Maier; A Hinz
Journal:  Schmerz       Date:  2009-06       Impact factor: 1.107

10.  Development of a self-reporting tool to obtain a combined index of severity of fibromyalgia (ICAF).

Authors:  Miguel A Vallejo; Javier Rivera; Joaquim Esteve-Vives
Journal:  Health Qual Life Outcomes       Date:  2010-01-07       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.